Dialysis and Renal Disease Management
Moving in Annals of Internal Medicine.
- Moved, week to 17 Nov 2026
- 1
- Papers in 60 days
- 69
Rebuilt
Moved this week
Latest in Dialysis and Renal Disease Management
Newest first · last 60 days
AI summary · may contain errors
Lower household income (<$25,000 vs $200,000 or more) is linked to higher all-cause mortality and worse kidney outcomes in 218,098 All of Us participants.
- Open access
AI summary · may contain errors
An updated kidney replacement Roadmap calls for integrative, patient-centered strategies that merge engineering, biology, and design to accelerate translation of next-generation therapies.
AI summary · may contain errors
Chronic kidney disease, dialysis, and transplantation show that albumin’s diagnostic and therapeutic relevance extends beyond quantity, with emerging evidence that restoring albumin quality may matter.
AI summary · may contain errors
In older UK adults with kidney failure and frailty or multimorbidity, preparing for responsive management did not improve QALYs versus preparing for renal dialysis (adjusted difference -0.147; p=0.16) over 4.5 years.
- Open access
AI summary · may contain errors
Systemic inflammation marked by high-sensitivity C-reactive protein (hsCRP) is associated with higher cardiovascular event risk and CKD progression in chronic kidney disease.
- 3 cites
AI summary · may contain errors
In the German CKD study (GCKD; 5085 participants), EKFC eGFR reclassified women more often than men into milder KDIGO GFR stages, with 4- to 5.7-fold fewer classified as having CKD.
- Open access
- 1 cites
AI summary · may contain errors
A hypothesis-generating model of AA amyloidosis predicts a threshold in kidney aggregation dynamics where autocatalytic oligomer production balances oligomer loss, producing a transcritical bifurcation.
- Open access
AI summary · may contain errors
Nondialyzable β-blockers at hemodialysis initiation are linked to lower 6-month, 1-year, and 3-year MACE risk versus dialyzable β-blockers, with hazard ratios down to 0.82.
- Open access
- 6 cites
AI summary · may contain errors
Five pragmatic randomized trials of routine hemodialysis care used altered consent processes across interventions, showing they can be ethically acceptable while enabling rigorous trial conduct.
- Open access
AI summary · may contain errors
In a community survey of 346 adults in San Antonio, Texas, knowing a living kidney donor was linked to higher willingness (OR 2.82, 95% CI 1.33–5.95).
- Open access
AI summary · may contain errors
Semaglutide is linked to lower mortality on dialysis than dulaglutide or liraglutide in U.S. Medicare hemodialysis patients with diabetes, with sHR 0.82 (95% CI 0.70–0.97).
Browse JClub
Journals this month
- bioRxiv6357
- medRxiv1736
- PNAS556
- JAMA352
- Sci Adv330
- Cell Rep314
- Environ Res213
- BMJ209
- EHJ206
- Nat Commun172
- NAR172
- Plant Cell Environ167
- Environ Pollution153
- Science152
- NEJM148
- New Phytol145
- Curr Biol130
- Nature127
Topics moving, week to 17 Nov 2026
- Single-cell and spatial transcriptomics10
- Gut microbiota and health6
- CAR-T cell therapy research6
- Pancreatic and Hepatic Oncology Research5
- Genomics and Chromatin Dynamics5
- Inflammatory Bowel Disease5
- Lung Cancer Treatments and Mutations5
- Antibiotic Resistance in Bacteria5
- Genomics and Phylogenetic Studies4
- Lipoproteins and Cardiovascular Health4
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
